Cardiometabolic features alone can categorize a patient as having metabolic dysfunction-associated steatotic liver disease (MASLD).

“how we get at staging of disease and progression um is dependent on multiple risk factors um but the the take-home point to what you're asking in terms of teasing out cardiometabolic risk we have all the parameters that are listed and they vary a little bit by ethnicity so any one of those cardom metabolic um features will sort of start to push you into the category of metabolic dysfunction associated setic liver disease or massel”